Stocks and Investing
Stocks and Investing
Thu, September 12, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Rohit Vanjani Initiated (TEVA) at Hold on, Sep 12th, 2019
Rohit Vanjani of Guggenheim, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold on, Sep 12th, 2019.
Rohit has made no other calls on TEVA in the last 4 months.
There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 2 agree with Rohit's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vamil Divan of "Credit Suisse" Initiated at Hold on, Wednesday, July 10th, 2019
- Kevin Caliendo of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $12 on, Tuesday, May 28th, 2019
These are the ratings of the 4 analyists that currently disagree with Rohit
- Chris Schott of "JP Morgan" Maintained at Sell with Decreased Target to $7 on, Friday, September 6th, 2019
- David Risinger of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $6 on, Monday, July 15th, 2019
- Douglas Tsao of "Barclays" Initiated at Sell and Held Target at $8 on, Tuesday, June 11th, 2019
- Jason Gerberry of "B of A Securities" Downgraded from Strong Buy to Sell and Decreased Target to $9 on, Thursday, May 30th, 2019